quantisnow
FeedTopReportsPricing
⌘K
Live feed
07:00:00·534d
PRRelease
AbbVie Inc. logo
C4 Therapeutics Inc. logo
ImmunoGen Inc. logo
+1

Seaport Therapeutics Names Lauren White as Chief Financial Officer

ABBV· AbbVie Inc.CCCC· C4 Therapeutics Inc.IMGN· ImmunoGen Inc.NVS· Novartis AG
Health Care
Original source

Companies

  • ABBV
    AbbVie Inc.
    Health Care
  • CCCC
    C4 Therapeutics Inc.
    Health Care
  • IMGN
    ImmunoGen Inc.
    Health Care
  • NVS
    Novartis AG
    Health Care

Recent analyst ratings

  • Apr 21ABBVUpdateCanaccord Genuity$262.00
  • Mar 11NVSUpdateArgus$180.00
  • Feb 25ABBVUpdateRBC Capital Mkts$260.00
  • Feb 20ABBVUpdateBarclays$275.00
  • Jan 27NVSUpdateCitigroup-
  • Jan 8ABBVUpdateWolfe Research-

Related

  • PR10h
    AbbVie Provides Update on TrenibotulinumtoxinE (TrenibotE) Biologics License Application in the U.S.
  • SEC1d
    Amendment: SEC Form SCHEDULE 13G/A filed by C4 Therapeutics Inc.
  • PR1d
    AbbVie Selects North Carolina for New $1.4 Billion Manufacturing Campus
  • ANALYST2d
    Canaccord Genuity initiated coverage on AbbVie with a new price target
  • PR3d
    AbbVie and BioLabs Team Up to Support Life Sciences Innovation in Canada
  • PR9d
    Erin Lichy Gets Real About Her Natrelle® Breast Augmentation
  • PR10d
    Haisco Enters into Exclusive License Agreement with AbbVie to Develop Novel Medicines for Pain
  • PR11d
    AbbVie Showcases Late‑Breaking Phase 2 Data for Mirvetuximab Soravtansine-gynx (ELAHERE®) in Platinum‑Sensitive Ovarian Cancer (PSOC) at SGO 2026
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022